Scientists at the University of East Anglia have developed a breakthrough blood test capable of diagnosing Chronic Fatigue Syndrome (CFS/ME) with up to 96% accuracy. Using EpiSwitch® 3D genomic technology, the test identifies unique DNA patterns that act as a biological signature of the disease — offering the first tangible biomarker for a condition long dismissed as psychological. This innovation could revolutionize diagnosis, treatment, and understanding of both CFS and Long COVID.
International Research Awards on Advanced Nanomaterials and Nanotechnology
36th Edition, 28 -29 November 2025 | Agra, India
Visit Our Website: nanotech.sciencefather.com
Award Nomination: https://nanotechnology-conferences.sciencefather.com/award-nomination/?ecategory=Awards&rcategory=Awardee
Contact Us: nanotech@sciencefather.com
Get Connected Here:
=================
Youtube: https://www.youtube.com/@nanotechnologyresearch3435
Twitter: https://x.com/nanotech_award
Instagram: https://www.instagram.com/nanotechnologyawards/
Pinterest: https://in.pinterest.com/nanotechnology456/
Tumblr: https://www.tumblr.com/blog/nanotechnologyresearchawards
#ScienceFather #scifax #researcherawards #phd #researcher #ANNAwards #nanotechnology #NanotechnologyAwards #ChronicFatigueSyndrome #CFSBreakthrough #MEBiomarker #BloodTestInnovation #EpiSwitch #UniversityOfEastAnglia #MedicalDiscovery #GenomicResearch #LongCOVID #PrecisionMedicine #ChronicIllness #HealthTech #BiomedicalInnovation #ScienceNews #CFSResearch #Genomics #MedicalBreakthrough #FatigueSyndrome #ClinicalResearch #ScienceUpdate
No comments:
Post a Comment